Trial Profile
Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Female infertility; Ovarian disorders
- Focus Therapeutic Use
- Acronyms OVARONKO
- 23 Jan 2013 New trial record